Sun Seeks Acquisitions, Partners To Enter Japan Market In Big Way
This article was originally published in PharmAsia News
Executive Summary
A Sun Pharmaceutical Industries executive said the company wants to challenge Lupin's status as the only India drug maker with a significant presence in Japan and plans to buy or partner with firms to get it done.